A detailed history of Great West Life Assurance CO transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 45,632 shares of FATE stock, worth $75,749. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,632
Previous 42,166 8.22%
Holding current value
$75,749
Previous $138,000 15.94%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.12 - $5.57 $10,813 - $19,305
3,466 Added 8.22%
45,632 $160,000
Q2 2024

Aug 12, 2024

BUY
$3.26 - $7.08 $100,818 - $218,956
30,926 Added 275.14%
42,166 $138,000
Q1 2024

May 13, 2024

BUY
$3.54 - $8.35 $5,805 - $13,694
1,640 Added 17.08%
11,240 $82,000
Q4 2023

Feb 13, 2024

SELL
$1.65 - $3.94 $1,115 - $2,663
-676 Reduced 6.58%
9,600 $36,000
Q2 2023

Aug 10, 2023

BUY
$4.76 - $6.59 $27,565 - $38,162
5,791 Added 129.12%
10,276 $49,000
Q1 2023

May 12, 2023

BUY
$4.24 - $11.12 $1,212 - $3,180
286 Added 6.81%
4,485 $26,000
Q4 2022

Feb 10, 2023

BUY
$9.86 - $23.83 $1,646 - $3,979
167 Added 4.14%
4,199 $42,000
Q3 2022

Nov 01, 2022

BUY
$21.04 - $36.06 $84,833 - $145,393
4,032 New
4,032 $91,000
Q2 2022

Aug 09, 2022

BUY
$17.78 - $42.39 $1,120 - $2,670
63 Added 1.61%
3,965 $99,000
Q1 2022

May 12, 2022

SELL
$29.67 - $60.28 $14,745 - $29,959
-497 Reduced 11.3%
3,902 $161,000
Q4 2021

Feb 14, 2022

BUY
$47.84 - $64.34 $2,870 - $3,860
60 Added 1.38%
4,399 $257,000
Q2 2021

Aug 11, 2021

SELL
$67.25 - $92.52 $941 - $1,295
-14 Reduced 0.32%
4,339 $376,000
Q1 2021

May 17, 2021

BUY
$72.16 - $117.4 $4,040 - $6,574
56 Added 1.3%
4,353 $356,000
Q3 2020

Nov 17, 2020

BUY
$30.41 - $40.5 $130,671 - $174,028
4,297 New
4,297 $171,000
Q3 2020

Nov 13, 2020

SELL
$30.41 - $40.5 $130,671 - $174,028
-4,297 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$13.39 - $20.73 $57,536 - $89,076
4,297 New
4,297 $84,000
Q3 2019

Oct 25, 2019

SELL
$15.47 - $22.5 $123,806 - $180,067
-8,003 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$9.16 - $13.48 $73,307 - $107,880
8,003 New
8,003 $91,000

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $161M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.